← Leaderboards
Barry M. Lester
Emma Pendleton Bradley Hospital
$39,430,921
Attributed
$58,524,853
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2005–24$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$62,917,657 · 14
By mechanism
R01$30,190,204 · 6
UH3$18,368,895 · 1
U10$8,129,933 · 2
UG3$5,211,652 · 1
R21$523,973 · 1
N01$385,000 · 1
Top collaborators
- Carmen Joseph Marsit11 shared
- Liz D Conradt6 shared
- Jonathan M. Davis6 shared
- T Michael O'Shea6 shared
- Todd M Everson5 shared
Others in their field
Top investigators on “Infant”
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Carol Nesel · Westat$188,148,170
- Barbara Driver · Westat, Inc.$184,782,231
- Abhik Das · Research Triangle Institute$178,442,979
- Elizabeth A Thom · George Washington University$170,837,172
- J Brooks Jackson · Social And Scientific Systems, Inc.$150,941,831
Research focus
InfantAffectMedicalAdultFollow-UpBirthPregnancySiteChildBaseCohortUnited States National Institutes Of HealthNeurobehaviorPostnatalPharmaceutical PreparationsImpairmentLeadNeurobehavioralEnvironmentNeonatalMotorBehavioralNeurodevelopmentChildhood
Grant awards (65)
Clinical markers of neonatal opioid withdrawal syndrome: onset, severity and longitudinal neurodevelopmental outcome$768,958
R01 · FY2024 · DA · contact PI
Clinical markers of neonatal opioid withdrawal syndrome: onset, severity and longitudinal neurodevelopmental outcome$774,454
R01 · FY2023 · DA · contact PI
Epigenetic Markers, Trajectories and Predictors of Neurodevelopment in Childhood among Infants Born Very Preterm$631,523
R01 · FY2023 · HD · contact PI
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$3,899,402
UH3 · FY2022 · OD · contact PI
Clinical markers of neonatal opioid withdrawal syndrome: onset, severity and longitudinal neurodevelopmental outcome$773,273
R01 · FY2022 · DA · contact PI
Epigenetic Markers, Trajectories and Predictors of Neurodevelopment in Childhood among Infants Born Very Preterm$641,465
R01 · FY2022 · HD · contact PI
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$65,023
UH3 · FY2022 · OD · contact PI
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$3,299,402
UH3 · FY2021 · OD · contact PI
Clinical markers of neonatal opioid withdrawal syndrome: onset, severity and longitudinal neurodevelopmental outcome$778,715
R01 · FY2021 · DA · contact PI
Epigenetic Markers, Trajectories and Predictors of Neurodevelopment in Childhood among Infants Born Very Preterm$642,828
R01 · FY2021 · HD · contact PI
Clinical markers of neonatal opioid withdrawal syndrome: onset, severity and longitudinal neurodevelopmental outcome$175,593
R01 · FY2021 · DA · contact PI
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$65,023
UH3 · FY2021 · OD · contact PI
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$2,869,781
UH3 · FY2020 · OD · contact PI
Clinical markers of neonatal opioid withdrawal syndrome: onset, severity and longitudinal neurodevelopmental outcome$801,628
R01 · FY2020 · DA · contact PI
Epigenetic Markers, Trajectories and Predictors of Neurodevelopment in Childhood among Infants Born Very Preterm$687,600
R01 · FY2020 · HD · contact PI
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$4,245,455
UH3 · FY2019 · OD · contact PI
Epigenetic Markers, Trajectories and Predictors of Neurodevelopment in Childhood among Infants Born Very Preterm$716,256
R01 · FY2019 · HD · contact PI
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$3,924,809
UH3 · FY2018 · OD · contact PI
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$3,668,723
UG3 · FY2017 · OD · contact PI
Neonatal Neurobehavior and Outcomes in Very Preterm Infants$552,759
R01 · FY2017 · HD · contact PI
Epigenetic Predictors of Impairment in Very Preterm Infants$293,847
R01 · FY2017 · HD · contact PI
Establishing Risk in Neonatal Abstinence Syndrome$272,941
R21 · FY2017 · DA
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$1,542,929
UG3 · FY2016 · OD · contact PI
Neonatal Neurobehavior and Outcomes in Very Preterm Infants$609,225
R01 · FY2016 · HD · contact PI
Epigenetic Predictors of Impairment in Very Preterm Infants$303,575
R01 · FY2016 · HD · contact PI
Establishing Risk in Neonatal Abstinence Syndrome$251,032
R21 · FY2016 · DA
Improving Outcome in Neonatal Abstinence Syndrome$670,027
R01 · FY2015 · DA
Neonatal Neurobehavior and Outcomes in Very Preterm Infants$607,369
R01 · FY2015 · HD · contact PI
Neonatal Neurobehavior and Outcomes in Very Preterm Infants$707,156
R01 · FY2014 · HD · contact PI
Improving Outcome in Neonatal Abstinence Syndrome$692,998
R01 · FY2014 · DA
Neonatal Neurobehavior and Outcomes in Very Preterm Infants$100,000
R01 · FY2014 · HD · contact PI
Neonatal Neurobehavior and Outcomes in Very Preterm Infants$698,622
R01 · FY2013 · HD · contact PI
Improving Outcome in Neonatal Abstinence Syndrome$671,937
R01 · FY2013 · DA
Prenatal Methamphetamine Exposure and School Aged Outcome$172,667
R01 · FY2013 · DA · contact PI
Prenatal Methamphetamine Exposure and School Aged Outcome$1,396,762
R01 · FY2012 · DA · contact PI
Improving Outcome in Neonatal Abstinence Syndrome$783,536
R01 · FY2012 · DA
Maternal Lifestyle Study Phase 5$138,505
U10 · FY2011 · DA · contact PI
Prenatal Methamphetamine Exposure and School Aged Outcome$1,473,855
R01 · FY2010 · DA · contact PI
COMMON PROTOCOL$1,314,813
U10 · FY2010 · DA · contact PI
Maternal Lifestyle Study Phase 5$1,314,813
U10 · FY2010 · DA · contact PI
Behavioral Epigenetics$58,000
R13 · FY2010 · DA · contact PI
Prenatal Methamphetamine Exposure and School Aged Outcome$1,516,431
R01 · FY2009 · DA · contact PI
COMMON PROTOCOL$1,327,142
U10 · FY2009 · DA · contact PI
Maternal Lifestyle Study Phase 5$1,327,142
U10 · FY2009 · DA · contact PI
Maternal Opioid Treatment: Human Experimental Research$350,935
R01 · FY2009 · DA · contact PI
Prenatal Methamphetamine Exposure and School Aged Outcome$1,435,676
R01 · FY2008 · DA · contact PI
Maternal Lifestyle Study Phase 5$542,239
U10 · FY2008 · DA · contact PI
COMMON PROTOCOL$542,239
U10 · FY2008 · DA · contact PI
Maternal Lifestyle Study Phase 5$427,320
U10 · FY2008 · DA · contact PI
Maternal Lifestyle Study Phase 5$89,850
U10 · FY2008 · DA · contact PI
Prenatal Methamphetamine Exposure and School Aged Outcome$1,442,564
R01 · FY2007 · DA · contact PI
COMMON PROTOCOL$552,935
U10 · FY2007 · DA · contact PI
Maternal Lifestyle Study Phase 5$552,935
U10 · FY2007 · DA · contact PI
Maternal Opioid Treatment: Human Experimental Research$413,404
R01 · FY2006 · DA · contact PI
Resilience in Children$50,000
R13 · FY2006 · DA · contact PI
Prental Methamphetamine Exposure and Child Development$1,256,221
R01 · FY2005 · DA
Maternal Opioid Treatment: Human Experimental Research$387,309
R01 · FY2005 · DA
Prental Methamphetamine Exposure and Child Development$1,317,390
R01 · FY2004 · DA
Maternal Opioid Treatment: Human Experimental Research$432,768
R01 · FY2004 · DA
Prental Methamphetamine Exposure and Child Development$166,473
R01 · FY2004 · DA
Prental Methamphetamine Exposure and Child Development$1,200,937
R01 · FY2003 · DA
Prental Methamphetamine Exposure and Child Development$91,680
R01 · FY2003 · DA
Prental Methamphetamine Exposure and Child Development$1,502,457
R01 · FY2002 · DA
Prenatal Methamphetamine Exposure and Child Development$1,549,331
R01 · FY2001 · DA
NEURODEVELOPMENT OF INFANTS EXPOSED TO DRUGS IN-UTERO$385,000
N01 · FY2000 · HD